Recall Record

Carlsbad, CA, United States

Qualigen Inc recalls

3 recalls recorded since 2018, most recently on 3 December 2024. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)2
Terminated or completed1
Class I (FDA)0

Ongoing Class III Medical devices

Recall started
3 December 2024
Reason
Three lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 2408018-1, 2409015-1, and 2409015-2. The likelihood of patient harm is expected to be low as routine Quality Control should detect kits that are impacted by signal deterioration due to age.
Distribution
Distribution was made to AR, CA, CO, FL, IL, IN, MA, MO, NC, NY, OH, OK, TN, TX, and VA. There was no military/government/foreign distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0805-2025

Ongoing Class II Medical devices

Recall started
26 August 2024
Reason
Thyroid Stimulating Hormone (TSH) calibrator card has an incorrect barcode linked to incorrect information, that may allow successful system calibration, but the TSH results obtained could be higher than expected.
Distribution
US: TX, MS, NY, OH, MT, WA, PA, MN, SC, GA, NC, NV, WY, AK, SD, KS, NE, VT, AL, MA, OK, UT, WI, IA, WV. OUS: Germany, Switzerland
Initiated
Voluntary: Firm initiated
Recall number
Z-0022-2025

Terminated Class II Medical devices

Recall started
6 November 2019
Terminated
23 September 2020
Reason
The chemiluminescent immunoassay has been noted to have higher than expected results which may result in inaccurate quantitative determinations of Sex Hormone Binding Globulin in human serum and plasma.
Distribution
US Nationwide distribution in the states of AL, AK, CA, HI, and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-1672-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.